MAPT and Alzheimer disease: Beyond GSK3β, c-Jun N-terminal kinases (JNKs) have been shown to play a critical role in driving the hyperphosphorylation of Tau in cell culture systems, AD models, and in the brain of AD patients [66,67,68,69].